Scott Alexander O'Brien Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Scott Alexander O'Brien.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Scott Alexander O'Brien. Scott Alexander O'Brien is SVP, Global Mktg & Int'l Sales in GenMark Diagnostics, Inc. ($GNMK).
Latest Insider Trading Transactions of Scott Alexander O'Brien
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 22 2021 | GNMK | GenMark Diagnostic ... | O'Brien Scott Alexander | SVP, Global Mktg & ... | Option Exercise | D | 10.89 | 1,500 | 16,335 | 0 | |
Apr 22 2021 | GNMK | GenMark Diagnostic ... | O'Brien Scott Alexander | SVP, Global Mktg & ... | Option Exercise | D | 12.30 | 5,200 | 63,960 | 0 | |
Apr 22 2021 | GNMK | GenMark Diagnostic ... | O'Brien Scott Alexander | SVP, Global Mktg & ... | Option Exercise | D | 13.17 | 8,500 | 111,945 | 0 | |
Apr 22 2021 | GNMK | GenMark Diagnostic ... | O'Brien Scott Alexander | SVP, Global Mktg & ... | Option Exercise | D | 7.90 | 10,000 | 79,000 | 0 | |
Apr 22 2021 | GNMK | GenMark Diagnostic ... | O'Brien Scott Alexander | SVP, Global Mktg & ... | Option Exercise | D | 0.00 | 25,000 | 0 | 0 | |
Apr 22 2021 | GNMK | GenMark Diagnostic ... | O'Brien Scott Alexander | SVP, Global Mktg & ... | Option Exercise | D | 0.00 | 33,334 | 0 | 0 | |
Apr 22 2021 | GNMK | GenMark Diagnostic ... | O'Brien Scott Alexander | SVP, Global Mktg & ... | Sell | U | 24.05 | 170,879 | 4,109,640 | 0 | 170.9 K to 0 (-100.00 %) |
Mar 08 2021 | GNMK | GenMark Diagnostic ... | O'Brien Scott Alexander | SVP, Global Mktg & ... | Payment of Exercise | F | 0.00 | 735 | 0 | 170,879 | 171.6 K to 170.9 K (-0.43 %) |
Mar 01 2021 | GNMK | GenMark Diagnostic ... | O'Brien Scott Alexander | SVP, Global Mktg & ... | Payment of Exercise | F | 0.00 | 9,726 | 0 | 171,614 | 181.3 K to 171.6 K (-5.36 %) |
Feb 25 2021 | GNMK | GenMark Diagnostic ... | O'Brien Scott Alexander | SVP, Global Mktg & ... | Payment of Exercise | F | 0.00 | 735 | 0 | 181,340 | 182.1 K to 181.3 K (-0.40 %) |
Feb 24 2021 | GNMK | GenMark Diagnostic ... | O'Brien Scott Alexander | SVP, Global Mktg & ... | Payment of Exercise | F | 0.00 | 390 | 0 | 182,075 | 182.5 K to 182.1 K (-0.21 %) |
Feb 22 2021 | GNMK | GenMark Diagnostic ... | O'Brien Scott Alexander | SVP, Global Mktg & ... | Option Exercise | A | 0.00 | 12,500 | 0 | 12,500 | |
Feb 22 2021 | GNMK | GenMark Diagnostic ... | O'Brien Scott Alexander | SVP, Global Mktg & ... | Grant | A | 0.00 | 37,500 | 0 | 182,465 | 145 K to 182.5 K (+25.87 %) |
Jan 29 2021 | GNMK | GenMark Diagnostic ... | O'Brien Scott Alexander | SVP, Global Mktg & ... | Sell | S | 14.06 | 180 | 2,531 | 144,965 | 145.1 K to 145 K (-0.12 %) |
Jan 25 2021 | GNMK | GenMark Diagnostic ... | O'Brien Scott Alexander | SVP, Global Mktg & ... | Option Exercise | M | 0.00 | 16,666 | 0 | 16,667 | |
Jan 25 2021 | GNMK | GenMark Diagnostic ... | O'Brien Scott Alexander | SVP, Global Mktg & ... | Sell | S | 14.23 | 6,458 | 91,897 | 145,145 | 151.6 K to 145.1 K (-4.26 %) |
Jan 25 2021 | GNMK | GenMark Diagnostic ... | O'Brien Scott Alexander | SVP, Global Mktg & ... | Buy | M | 0.00 | 16,666 | 0 | 151,603 | 134.9 K to 151.6 K (+12.35 %) |
Dec 09 2020 | GNMK | GenMark Diagnostic ... | O'Brien Scott Alexander | SVP, Global Mktg & ... | Sell | S | 13.97 | 742 | 10,366 | 134,937 | 135.7 K to 134.9 K (-0.55 %) |
Oct 29 2020 | GNMK | GenMark Diagnostic ... | O'Brien Scott Alexander | SVP, Global Mktg & ... | Sell | S | 11.34 | 177 | 2,007 | 137,035 | 137.2 K to 137 K (-0.13 %) |
Sep 10 2020 | GNMK | GenMark Diagnostic ... | O'Brien Scott Alexander | SVP, Global Mktg & ... | Sell | S | 11.02 | 770 | 8,485 | 137,212 | 138 K to 137.2 K (-0.56 %) |
Aug 26 2020 | GNMK | GenMark Diagnostic ... | O'Brien Scott Alexander | SVP, Global Mktg & ... | Sell | S | 14.14 | 1,223 | 17,293 | 137,982 | 139.2 K to 138 K (-0.88 %) |
Aug 18 2020 | GNMK | GenMark Diagnostic ... | O'Brien Scott Alexander | SVP, Global Mktg & ... | Sell | S | 15.38 | 36,570 | 562,447 | 139,205 | 175.8 K to 139.2 K (-20.81 %) |
Aug 05 2020 | GNMK | GenMark Diagnostic ... | O'Brien Scott Alexander | SVP, Global Mktg & ... | Sell | S | 18.93 | 208 | 3,937 | 175,775 | 176 K to 175.8 K (-0.12 %) |
Jul 29 2020 | GNMK | GenMark Diagnostic ... | O'Brien Scott Alexander | SVP, Global Mktg & ... | Sell | S | 17.30 | 170 | 2,941 | 175,983 | 176.2 K to 176 K (-0.10 %) |
Jun 09 2020 | GNMK | GenMark Diagnostic ... | O'Brien Scott Alexander | SVP, Global Mktg & ... | Sell | S | 9.14 | 780 | 7,129 | 176,153 | 176.9 K to 176.2 K (-0.44 %) |
Jun 01 2020 | GNMK | GenMark Diagnostic ... | O'Brien Scott Alexander | SVP, Global Mktg & ... | Sell | S | 9.52 | 1,179 | 11,224 | 176,933 | 178.1 K to 176.9 K (-0.66 %) |
May 06 2020 | GNMK | GenMark Diagnostic ... | O'Brien Scott Alexander | SVP, Global Mktg & ... | Sell | S | 13.49 | 236 | 3,184 | 178,112 | 178.3 K to 178.1 K (-0.13 %) |
May 01 2020 | GNMK | GenMark Diagnostic ... | O'Brien Scott Alexander | SVP, Global Mktg & ... | Sell | S | 11.64 | 168 | 1,956 | 178,348 | 178.5 K to 178.3 K (-0.09 %) |
Page: 1